edaravone
CHEBI:CHEBI_31530
Definition
A pyrazolone that is 2,4-dihydro-3H-pyrazol-3-one which is substituted at positions 2 and 5 by phenyl and methyl groups, respectively.
Chemical Information
- Molecular Formula
- C10H10N2O
- Molecular Mass
- 174.19920
- Charge
- 0
- SMILES
- CC1=NN(C(=O)C1)c1ccccc1
- InChI
- InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
- InChIKey
- QELUYTUMUWHWMC-UHFFFAOYSA-N
Alternative Names
- 1-phenyl-3-methyl-5-oxo-2-pyrazoline
- 2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
- 3-methyl-1-phenyl-2-pyrazolin-5-one
- 3-methyl-1-phenyl-5-pyrazolone
- 3-methyl-1-phenylpyrazol-5-one
- 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
- C.I. developer 1
- developer Z
- Edaravone
- methylphenylpyrazolone
- norphenazone
- phenyl methyl pyrazolone
- phenylmethylpyrazolone
- Radicut
Drug Classification
-
pyrazoloneView Class →
CHEBI:83328
-
t179833
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:31530
- DRON_00010000
- 1921877
- oboInOwl#hasDbXref
- PMID:27128210
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- rxcui
- 2602122
- listing_expiration_date
- 20241231
- route
- INTRAVENOUS
- marketing_start_date
- 20170505
- package_marketing_start_date
- 05-MAY-17
- active_ingredient_strength
- 60 mg/100mL
- active_ingredient_name
- EDARAVONE
- spl_id
- a3e1b505-4b4d-446f-b02d-f12709cb1637
- package_ndc
- 53296-0120-0
- package_description
- 75 kg in 1 DRUM (53296-0120-0)
- manufacturer_name
- Mitsubishi Tanabe Pharma America, Inc.
- unii
- S798V6YJRP
- spl_set_id
- 19862ae9-d6e1-70e6-e063-6394a90ae749
- labeler_name
- Long Grove Pharmaceuticals, LLC
- upc
- 0370510232315
- core#notation
- CHEBI:31530
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1921877
- oboInOwl#hasDbXref
- PMID:27128210
- oboInOwl#id
- CHEBI:31530
- generic_name
- EDARAVONE
- brand_name
- RADICAVA
- brand_name_base
- RADICAVA
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- INJECTION, SOLUTION
- product_ndc
- 53296-0120
- application_number
- NDA209176
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_48578
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0111246
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect16932
- owl#annotatedSource
- t180305
- owl#someValuesFrom
- t3879512